AQST Operating Cash Flow (Statement)
Aquestive Therapeutics Inc · Operating Cash Flow (Statement)
AQST Operating Cash Flow (Statement)
Latest reported-$45.37Mperiod ending
AQST Cash from Operations (-$8.18M → -$45.37M)
Annual operating cash flow (statement)
High-resolution chart · PNG
AQST operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -52,432,000 | |
| -35,759,000 | |
| -6,380,000 | |
| -9,789,000 | |
| -32,979,000 | |
| -45,459,000 | |
| -60,210,000 | |
| -12,991,000 | |
| 5,824,000 | |
| -8,175,000 |